Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1268, 2000-01, pp. : 21-21
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Amendments to the requirements for brandname-drug patents have been proposed by the US FDA
Inpharma, Vol. 1, Iss. 1368, 2002-01 ,pp. :
Spontaneous Adverse Drug Reaction Reporting in Rural Districts of Mozambique
Drug Safety, Vol. 31, Iss. 10, 2008-01 ,pp. :